Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Skinbiotherapeutics Plc LSE:SBTX London Ordinary Share GB00BF33H870 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.625 3.73% 17.375 390,222 14:46:02
Bid Price Offer Price High Price Low Price Open Price
17.00 17.75 17.375 16.75 16.75
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology -1.36 -0.94 21
Last Trade Time Trade Type Trade Size Trade Price Currency
16:22:46 O 900 17.75 GBX

Skinbiotherapeutics (SBTX) Latest News

More Skinbiotherapeutics News
Skinbiotherapeutics Takeover Rumours

Skinbiotherapeutics (SBTX) Discussions and Chat

Skinbiotherapeutics (SBTX) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2020-05-26 15:22:4717.75900159.75O
2020-05-26 14:46:5917.1029,3105,012.01O
2020-05-26 14:35:2017.106,0001,026.00O
2020-05-26 14:02:1917.1016,6062,839.63O
2020-05-26 13:39:2017.605,000880.00O
View all Skinbiotherapeutics trades in real-time

Skinbiotherapeutics (SBTX) Top Chat Posts

DateSubject
26/5/2020
09:20
Skinbiotherapeutics Daily Update: Skinbiotherapeutics Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker SBTX. The last closing price for Skinbiotherapeutics was 16.75p.
Skinbiotherapeutics Plc has a 4 week average price of 15.25p and a 12 week average price of 5.75p.
The 1 year high share price is 25.75p while the 1 year low share price is currently 5.75p.
There are currently 118,708,494 shares in issue and the average daily traded volume is 1,041,014 shares. The market capitalisation of Skinbiotherapeutics Plc is £20,625,600.83.
23/5/2020
10:04
rafboy: I agree Shrewdmole and let’s face most ladies would welcome an anti ageing cream that is science backed if they currently use one that is not. So I hope you are right that revenue and share price will appreciate at a decent level in due course. In fact my profit from very limited trading is adding to my shareholding here.
21/5/2020
07:53
gary hindsight: Shrewdie, thinking about your comment re croda and I am thinking the following. I could see that they might conceivably do it to ride on the back of increasing share price given they really seem to believe in the potential success of the product although I have no idea if this this is big enough for a billion pound ftse company or even part of their MO. If they were doing it in order to build a stake with a view of taking them out then why would they not just make an offer to buy them, right now the value is chicken feed for them. They would also need to get the opti vote on 32% holding for a takeover to succeed and I am not convinced opti would vote in favour right now. Too much upside in keeping it independent and this is probably the view of most PI's I guess. Would they want the other strands of the business? But WTFDIK
16/5/2020
17:30
zedder: If you've been done by autocorrect and meant to say feasible, then yes. If you're saying the share price getting to 30p within 12 months would be pretty feeble, then I love your optimism!
03/5/2020
12:55
alanrussell: So picking up from Stuart Ashman's comment in that article that he expects it to be about 18 to 24 months (from 12/19) to see a product hit the market, how long before the expectation of that really affects the share price? A certain amount is already in the price but might it be start 2021 before we see it push the price up or do we realistically have to wait until launch is announced? Any views?
30/4/2020
14:22
elrico: I thought Parsnip comments on the google forum worth copying here; "Reading your account of the exchange with Stuart Elric, I cannot disagree. I had previously said the share price should have a 2 at the front. Looking at the cost control within the business and obvious "activity" in the last week or so there is an awful lot of opportunity. I cannot oppose the CEO and therefore think it should have a 3 at the front. This still remains a bargain share in the roulette world of shares." For those of you not familiar with Parsnip, you will soon enough. He is on OPTI's share register, SBTX, AVA, and others. He is a bright fellow, you know. He has a few shillings too. :)
18/4/2020
09:49
18081: So why did the small SBTX share sale take place ? Surely it was linked to the fact that OPTI wanted as minimal share dilution as possible. The company required £1 million in funds when 3 million was offered and turned down. So the share sale of SBTX means OPTI doesn't dilute any further from the £2,500,000 new shares & the SBTX transaction makes up for the deduction of expenses of the main placing. Therefore giving OPTI the gross funds of what was required £1 million. Job done. Carry on....
22/11/2019
07:33
judijudi: Morning Trotts, I would like to see all these persistently negative comments of mine that have damaged and is damaging the share price (not the realistic ones, the persistently negative share price damaging ones you say I have posted) I really do look forward to reading them I have held sbtx since inception and been adding I have also held Opti for years and been adding I also feel these will both come good or I would have scarpered a long time ago Both have the potential to be massive I wouldn’t be holding them if I didn’t think so
04/7/2019
18:16
speccy1: Someone mentioned the divi to OPTI shareholders would hammer the SBTX share price. I believe the opposite will happen. The OPTI owned shares will be sold to an ii and so will be held. The cash will be given to OPTI shareholders. I intend to use mine to buy SBTX shares. How many others will do the same? If anything the divi will put a rocket up the SBTX share price imo.
28/7/2018
17:00
speccy1: The more I think about it, the more sense it makes to place the OPTI held shares with an institutional investor and pay a cash divi. If the sale includes a lock-in period, it not only safeguards the SBTX share price, but given many of the OPTI investors would use their divi to buy SBTX, it could significantly improve the share price. The problem could then be everyone fighting to spend their divi at once and a mass charge causing a short term spike. It would be a terrible dilemma whether to buy straight away or hang fire until the initial rush for shares has died down. First World problems :)
21/4/2018
21:46
onedayrodders: I posted this on OPTI board but will be of interest here .. Hey all, myself and Trotters were at the UK Investor show today and were chatting with SOH for quite a while.. I'm sure Trotters will be posting a few nuggets later but I know the SBTX divi is an Important issue many have asked about so here is what he said. They are absolutely aware and focused on making this as fair as possible by not allowing short term traders to benefit or damage either OPTI or SBTX share price. Options being discussed ... 1. Lock in period - Unlikely as regulators do not like this type of arrangement and view it as restricting the market. 2. Staggered benefit, for example, OPTI will give shareholders say 1000 SBTX shares and promise another 1000 shares the next year providing the first 1000 shares have not been sold. 3. Take advantage of increasing interest in Skinbiotix by selling a % of OPTI's stake in SBTX to by Institutional investors and delivering a SBTX cash divi. (Therefore delivering the SBTX divi promise, adding long term Institutional shareholders and removing volatility in the share price - my take) The qualifying for any divi, either shares or cash will be controlled by a record date and that cannot be a date in the past and will be from close of business on the day the divi details are announced. So they will be looking to time that towards the end of the day to allow the smallest window possible for the AIM trading vultures (my words not his !) That's from memory so hope I got it right (Trotters..correct me if I'm wrong) ODR
Skinbiotherapeutics share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
SBTX
Skinbiothe..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200527 04:06:18